Subject: 320503 Clinical Pharmacology and Therapeutics

Ding, C and Xu, J and Li, J (2008) ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases. Current Opinion in Investigational Drugs, 9 (5). pp. 515-522. ISSN 1472-4472

Peterson, GM and Naunton, M (2008) Asthma in the elderly. Australian Pharmacist, 27 (5). pp. 382-386. ISSN 0728-4632

Ding, C and Jones, G (2006) Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases. Reviews on Recent Clinical Trials, 1 (3). pp. 193-200. ISSN 1574-8871

Ding, C and Jones, G (2006) Belimumab (Human Genome Sciences/Cambridge Antibody Technology/GlaxoSmithKline). Current Opinion in Investigational Drugs, 7 (5). pp. 464-472. ISSN 1472-4472

Ding, C (2006) Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome. Current Opinion in Investigational Drugs, 7 (11). pp. 1020-1025. ISSN 1472-4472

Ding, C and Li, J and Zhang, X (2004) Bertilimumab (Cambridge Antibody Technology Group). Current Opinion in Investigational Drugs, 5 (11). pp. 1213-1219. ISSN 1472-4472

Ding, C and Li, Q and Xiong, ZY and Zhou, AW and Jones, G and Xu, SY (2003) Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis. Clinical & Experimental Immunology, 132 (3). pp. 416-423. ISSN 0009-9104

Ding, C and Cicuttini, F (2003) Licofelone (Merckle). IDrugs, 6 (8). pp. 802-808. ISSN 1369-7056

Ding, C and Jones, G (2003) Technology evaluation: MRA, Chugai. Current Opinion in Molecular Therapeutics, 5 (1). pp. 64-69. ISSN 1464-8431

Ding, C (2002) Do NSAIDs Affect the Progression of Osteoarthritis? Inflammation, 26 (3). pp. 139-142. ISSN 0360-3997

Ding, C and Jones, G (2002) Lumiracoxib (Novartis). IDrugs, 5 (12). pp. 1168-1172. ISSN 1369-7056

Peterson, GM and Tenni, PC and Hasan, O and Liauw, C and Reeve, J and Turner, P and Vial, JH Community Pharmacy Medication Incident and Reporting Management System (CPMIRMS) (PROMISe). UNSPECIFIED. UNSPECIFIED.

Peterson, GM and Liauw, C and Elkerton, JR and McKenzie, D and Fitzmaurice, KD Development and Evaluation of a computerised system for the provision and documentation of pharmacists' cognitive services. UNSPECIFIED. UNSPECIFIED.

Tenni, PC and Hughes, J and McCloskey, J and Hilmi, S Ensuring the appropriateness of topical over-the-counter antifungal agents for cllients with self-diagnosed vaginal thrush. UNSPECIFIED. UNSPECIFIED.

Peterson, GM and Tenni, PC and Kruup, HJ and Hasan, O and Pekarsky, B and Reeve, J Evalulation of clinical interventions within community pharmacy (PROMISs II). UNSPECIFIED. UNSPECIFIED.

Peterson, GM and Luttrell, D and Hughes, J and Raymond, K and Tompson, AJ and Jackson, SL and Hasan, O and Gee, PR and Nash, RE and Cooper, C and Fitzmaurice, KD and Roberts, BL Facilitating quality use of medicines between hospital and community (Med-E-Support). UNSPECIFIED. UNSPECIFIED.

Peterson, GM and Hughes, J and Stewart, K and Nation, R and Scott, S and Farris, K Pharmacy Cardiovascular Health Care Model. UNSPECIFIED. UNSPECIFIED.

Peterson, GM and Fitzmaurice, KD and Kruup, HJ and Jackson, SL and Ball, MJ and Rasiah, R Pharmacy-based program to tackle coronary heart disease in the Australian community. UNSPECIFIED. UNSPECIFIED.